Ingredient record · Blood pressure medicine (calcium channel blocker)
Nifedipine: bans, restrictions and failed batches in India
Last checked 20 September 2026. Sources: CDSCO banned-drugs notifications and monthly NSQ alerts, Jan 2019 to Jul 2026
No combination containing Nifedipine is on India's banned-drugs list. 9 batches of medicines containing Nifedipine failed a government lab test between May 2020 and July 2026, from 7 manufacturers. A failed batch concerns that batch only, not the medicine or every brand.
On the banned-drugs list
Nifedipine on its own is not on CDSCO's banned list. The entries below are specific combinations that contain it. Status follows CDSCO's own notes on each entry.
No entry containing Nifedipine is on the list compiled from CDSCO's Section 26A notifications (1983 to 2026). That is not a statement that every product containing it is safe.
Products that failed lab tests
Product names as printed by the testing labs, grouped. Open a product to see every batch number.
| Product | Batches | Makers | Latest |
|---|---|---|---|
| Nifedipine | 4 | 4 | Jul 2026 |
| Nifedipine Sustained Released | 2 | 1 | Apr 2026 |
| Nifedipine Sustain Release | 1 | 1 | Aug 2023 |
| Calnif Retard | 1 | 1 | May 2022 |
| Calcigard | 1 | 1 | May 2020 |
Most recent failed batches
| Product | Batch | Manufacturer | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|---|
| Nifedipine Sustained Release Tablets IP 10mg | ANY25001Mfg 2025-12 · Exp 2028-11 | J.B. Chemicals & Pharmaceuticals LtdGujarat | The sample does not conforms to the claim with respect to Dissolution (Acid Stage).Dissolution | DTL JaipurState lab | Jul 2026 |
| Nifedipine Sustained Released Tablet IP | NR019Mfg 2024-11 · Exp 2026-10 | Nabros Pharma Pvt. Ltd | DissolutionDissolution | FDL, VadodaraState lab | Apr 2026 |
| Nifedipine Sustained Released Tablet IP | NR019Mfg 2024-11 · Exp 2026-10 | Nabros Pharma Pvt. Ltd | DissolutionDissolution | FDL, VadodaraState lab | Mar 2026 |
| Nifedipine Sustained Release Tablets IP 20 mg | 3442505Mfg 2025-07 · Exp 2027-06 | Towa Pharma Private Limited | Dissolution Stage 1Dissolution | Food & Drugs Laboratory, VadodaraState lab | Nov 2025 |
| Nifedipine Sustained Release Tablets IP 10 mg | T250809Mfg 2025-08 · Exp 2027-07 | Medisky Pharmaceuticals Pvt. Ltd | Dissolution Stage 1Dissolution | Food & Drugs Laboratory, VadodaraState lab | Nov 2025 |
| Nifedipine Sustained Release Tablets IP 10 mg | NF24007Mfg 2024-08 · Exp 2026-01 | Eurokem Laboratories Pvt ltd | Sample does not conform to IP specification for Nifedipine Sustained Release Tablets with respect to the content of NifedipineOther | Drugs Testing Laboratory, Madurai-19State lab | May 2025 |
| Nifedipine Sustain Release Tablets I.P. 20 mg | T230307Mfg 2023-03 · Exp 2025-02 | Medisky Pharmaceuticals Pvt. LtdGujarat | DissolutionDissolution | CDL KolkataCDSCO lab | Aug 2023 |
| CALNIF RETARD (Nifedipine Prolonged Release Tablets I.P. 20 mg) | JKEG21006Mfg 2021-07 · Exp 2024-06 | Cadila Pharmaceuticals LimitedJammu & Kashmir | DissolutionDissolution | CDL KolkataCDSCO lab | May 2022 |
| Calcigard -10 (Nifedipine Capsules IP) | S175E004Mfg 2018-06 · Exp 2020-05 | Torrent Pharmaceuticals LtdDaman & Diu | DissolutionDissolution | CDL KolkataCDSCO lab | May 2020 |
Holding a strip or bottle? The batch number is printed after "B. No." Check it against every alert. If it matches, return it to the pharmacy. What the labels mean: status guide.